These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


158 related items for PubMed ID: 22525741

  • 21. New Insights in Genetic Cholestasis: From Molecular Mechanisms to Clinical Implications.
    Sticova E, Jirsa M, Pawłowska J.
    Can J Gastroenterol Hepatol; 2018; 2018():2313675. PubMed ID: 30148122
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Folding defects in P-type ATP 8B1 associated with hereditary cholestasis are ameliorated by 4-phenylbutyrate.
    van der Velden LM, Stapelbroek JM, Krieger E, van den Berghe PV, Berger R, Verhulst PM, Holthuis JC, Houwen RH, Klomp LW, van de Graaf SF.
    Hepatology; 2010 Jan; 51(1):286-96. PubMed ID: 19918981
    [Abstract] [Full Text] [Related]

  • 25. Unexpected clinical remission of cholestasis after rifampicin therapy in patients with normal or slightly increased levels of gamma-glutamyl transpeptidase.
    Cançado EL, Leitão RM, Carrilho FJ, Laudanna AA.
    Am J Gastroenterol; 1998 Sep; 93(9):1510-7. PubMed ID: 9732934
    [Abstract] [Full Text] [Related]

  • 26. Stimulation of bile acid 6 alpha-hydroxylation by rifampin.
    Wietholtz H, Marschall HU, Sjövall J, Matern S.
    J Hepatol; 1996 Jun; 24(6):713-8. PubMed ID: 8835747
    [Abstract] [Full Text] [Related]

  • 27. Case Report: A Rare Case of Benign Recurrent Intrahepatic Cholestasis-Type 1 With a Novel Heterozygous Pathogenic Variant of ATP8B1.
    Suzuki H, Arinaga-Hino T, Sano T, Mihara Y, Kusano H, Mizuochi T, Togawa T, Ito S, Ide T, Kuwahara R, Amano K, Kawaguchi T, Yano H, Kage M, Koga H, Torimura T.
    Front Med (Lausanne); 2022 Jun; 9():891659. PubMed ID: 35572954
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Two novel ATP8B1 mutations involved in progressive familial intrahepatic cholestasis type 1 that is ameliorated by rifampicin: A case report.
    Huang Y, Luo EP, Li M, Yang J, Gan JH, Zhao WF.
    J Dig Dis; 2022 Feb; 23(2):124-129. PubMed ID: 34985190
    [No Abstract] [Full Text] [Related]

  • 30. Intestinal bile salt absorption in Atp8b1 deficient mice.
    Groen A, Kunne C, Paulusma CC, Kramer W, Agellon LB, Bull LN, Oude Elferink RP.
    J Hepatol; 2007 Jul; 47(1):114-22. PubMed ID: 17448567
    [Abstract] [Full Text] [Related]

  • 31. Longitudinal profiles of 15 serum bile acids in patients with intrahepatic cholestasis of pregnancy.
    Tribe RM, Dann AT, Kenyon AP, Seed P, Shennan AH, Mallet A.
    Am J Gastroenterol; 2010 Mar; 105(3):585-95. PubMed ID: 19904249
    [Abstract] [Full Text] [Related]

  • 32. Molecular genetic and bile acid profiles in two Japanese patients with 3beta-hydroxy-DELTA5-C27-steroid dehydrogenase/isomerase deficiency.
    Mizuochi T, Kimura A, Ueki I, Takahashi T, Hashimoto T, Takao A, Seki Y, Takei H, Nittono H, Kurosawa T, Matsuishi T.
    Pediatr Res; 2010 Sep; 68(3):258-63. PubMed ID: 20531254
    [Abstract] [Full Text] [Related]

  • 33. Endoscopic nasobiliary drainage: an effective treatment option for benign recurrent intrahepatic cholestasis (BRIC).
    Choudhury A, Kulkarni AV, Sahoo B, Bihari C.
    BMJ Case Rep; 2017 May 05; 2017():. PubMed ID: 28476903
    [Abstract] [Full Text] [Related]

  • 34. Atp8b1 deficiency in mice reduces resistance of the canalicular membrane to hydrophobic bile salts and impairs bile salt transport.
    Paulusma CC, Groen A, Kunne C, Ho-Mok KS, Spijkerboer AL, Rudi de Waart D, Hoek FJ, Vreeling H, Hoeben KA, van Marle J, Pawlikowska L, Bull LN, Hofmann AF, Knisely AS, Oude Elferink RP.
    Hepatology; 2006 Jul 05; 44(1):195-204. PubMed ID: 16799980
    [Abstract] [Full Text] [Related]

  • 35. Prognostic roles of tetrahydroxy bile acids in infantile intrahepatic cholestasis.
    Lee CS, Kimura A, Wu JF, Ni YH, Hsu HY, Chang MH, Nittono H, Chen HL.
    J Lipid Res; 2017 Mar 05; 58(3):607-614. PubMed ID: 28073941
    [Abstract] [Full Text] [Related]

  • 36. Novel ATP8B1 mutation in an adult male with progressive familial intrahepatic cholestasis.
    Deng BC, Lv S, Cui W, Zhao R, Lu X, Wu J, Liu P.
    World J Gastroenterol; 2012 Nov 28; 18(44):6504-9. PubMed ID: 23197899
    [Abstract] [Full Text] [Related]

  • 37. Bile acid profiles in intrahepatic cholestasis of pregnancy: is this the solution to the enigma of intrahepatic cholestasis of pregnancy?
    Sinakos E, Lindor KD.
    Am J Gastroenterol; 2010 Mar 28; 105(3):596-8. PubMed ID: 20203641
    [Abstract] [Full Text] [Related]

  • 38. Nasobiliary drainage induces long-lasting remission in benign recurrent intrahepatic cholestasis.
    Stapelbroek JM, van Erpecum KJ, Klomp LW, Venneman NG, Schwartz TP, van Berge Henegouwen GP, Devlin J, van Nieuwkerk CM, Knisely AS, Houwen RH.
    Hepatology; 2006 Jan 28; 43(1):51-3. PubMed ID: 16374853
    [Abstract] [Full Text] [Related]

  • 39. Knockdown of ATP8B1 expression leads to specific downregulation of the bile acid sensor FXR in HepG2 cells: effect of the FXR agonist GW4064.
    Martínez-Fernández P, Hierro L, Jara P, Alvarez L.
    Am J Physiol Gastrointest Liver Physiol; 2009 May 28; 296(5):G1119-29. PubMed ID: 19228886
    [Abstract] [Full Text] [Related]

  • 40. The urinary bile acid excretion in healthy premature and full-term infants during the neonatal period.
    Strandvik B, Wahlén E, Wikström SA.
    Scand J Clin Lab Invest; 1994 Feb 28; 54(1):1-10. PubMed ID: 8171265
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.